Rationality of Antihypertensive Therapy and Blood Pressure Control in Comorbid Inpatients

Authors

  • Truly Anggraini Sekolah Tinggi Ilmu Kesehatan Nasional
  • Hartono Hartono Sekolah Tinggi Ilmu Kesehatan Nasional
  • Anita Mursiany Sekolah Tinggi Ilmu Kesehatan Nasional

DOI:

https://doi.org/10.37287/ijghr.v8i5.2469

Keywords:

antihypertensive, blood pressure control, comorbidity, rational prescribing, retrospective cohort

Abstract

Hypertension management in patients with comorbidities requires drug selection and dosing that are consistent with clinical conditions, organ function, and evidence-based recommendations. Inappropriate therapy may compromise blood pressure control and increase treatment-related risk. To evaluate the rationality of antihypertensive therapy and its association with blood pressure control among hospitalised patients with hypertension and comorbidities. An analytical retrospective cohort study used medical records from January to August 2025 at a public hospital in Central Java, Indonesia. Total sampling identified 76 eligible patients. Rational therapy required concordant assessments of right patient, right drug, and right dose. Blood pressure control was defined as a final measurement below 140/90 mmHg. Descriptive statistics, the Wilcoxon signed-rank test, and Fisher’s exact test were used. The mean age was 59.37 ± 13.01 years and 51.3% were male. Overall therapy was rational in 68 patients (89.5%); right-patient and right-dose criteria were each fulfilled in 98.7%, while right-drug criteria were fulfilled in 89.5%. Mean blood pressure declined from 187.39/100.24 mmHg to 133.07/81.89 mmHg (p<0.001). Forty-seven patients (61.8%) achieved control. Control occurred in 63.2% of the rational group and 50.0% of the non-rational group; the association was not statistically significant (OR 1.72; 95% CI 0.40–7.49; p=0.472). Most antihypertensive regimens met the documented rationality criteria and blood pressure improved substantially during hospitalisation. Although control was more frequent with rational therapy, the association was inconclusive because the non-rational group was small and inpatient outcomes were influenced by multiple clinical factors.

References

Abdelkader, N. N., Awaisu, A., Elewa, H., & El Hajj, M. S. (2023). Prescribing patterns of antihypertensive medications: A systematic review of literature between 2010 and 2020. Exploratory Research in Clinical and Social Pharmacy, 11, 100315. https://doi.org/10.1016/j.rcsop.2023.100315

Abegaz, T. M., Shehab, A., Gebreyohannes, E. A., Bhagavathula, A. S., & Elnour, A. A. (2017). Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine, 96(4), e5641. https://doi.org/10.1097/MD.0000000000005641

American Diabetes Association Professional Practice Committee. (2024). 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2024. Diabetes Care, 47(Suppl. 1), S179–S218. https://doi.org/10.2337/dc24-S010

Bress, A. P., Anderson, T. S., Flack, J. M., Ghazi, L., Hall, M. E., Laffer, C. L., Still, C. H., Taler, S. J., Zachrison, K. S., & Chang, T. I. (2024). The management of elevated blood pressure in the acute care setting: A scientific statement from the American Heart Association. Hypertension, 81(8), e94–e106. https://doi.org/10.1161/HYP.0000000000000238

Burnier, M., & Egan, B. M. (2019). Adherence in hypertension. Circulation Research, 124(7), 1124–1140. https://doi.org/10.1161/CIRCRESAHA.118.313220

Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., Lackland, D. T., Laffer, C. L., Newton-Cheh, C., Smith, S. M., Taler, S. J., Textor, S. C., Turan, T. N., & White, W. B. (2018). Resistant hypertension: Detection, evaluation, and management. Hypertension, 72(5), e53–e90. https://doi.org/10.1161/HYP.0000000000000084

Carey, R. M., Wright, J. T., Jr., Taler, S. J., & Whelton, P. K. (2021). Guideline-driven management of hypertension: An evidence-based update. Circulation Research, 128(7), 827–846. https://doi.org/10.1161/CIRCRESAHA.121.318083

Cheung, A. K., Whelton, P. K., Muntner, P., Schutte, A. E., Moran, A. E., Williams, B., Sarafidis, P., Chang, T. I., Daskalopoulou, S. S., Flack, J. M., Jennings, G., Juraschek, S. P., Kreutz, R., Mancia, G., Nesbitt, S., Ordunez, P., Padwal, R., Persu, A., Rabi, D., … Mann, J. F. E. (2023). International consensus on standardized clinic blood pressure measurement: A call to action. The American Journal of Medicine, 136(5), 438–445.e1. https://doi.org/10.1016/j.amjmed.2022.12.015

de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022). Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association and Kidney Disease: Improving Global Outcomes. Diabetes Care, 45(12), 3075–3090. https://doi.org/10.2337/dci22-0027

Du, L. P., Cheng, Z. W., Zhang, Y. X., Li, Y., & Mei, D. (2018). The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: A meta-analysis. Journal of Clinical Hypertension, 20(5), 902–907. https://doi.org/10.1111/jch.13272

Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016). Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. The Lancet, 387(10022), 957–967. https://doi.org/10.1016/S0140-6736(15)01225-8

Kalinić, D., Škrbić, R., Vulić, D., Stojaković, N., Stoisavljević-Šatara, S., Stojiljković, M. P., Marković-Peković, V., Golić Jelić, A., Pilipović-Broćeta, N., Wong, N. D., & Godman, B. (2022). Trends in antihypertensive medicine utilization in the Republic of Srpska, Bosnia and Herzegovina: An eleven-year follow-up. Frontiers in Pharmacology, 13, 889047. https://doi.org/10.3389/fphar.2022.889047

KDIGO Blood Pressure Work Group. (2021). KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney International, 99(3S), S1–S87. https://doi.org/10.1016/j.kint.2020.11.003

Li, Y. T., Wang, H. H. X., Liu, K. Q. L., Lee, G. K. Y., Chan, W. M., Griffiths, S. M., & Chen, R. L. (2016). Medication adherence and blood pressure control among hypertensive patients with coexisting long-term conditions in primary care settings: A cross-sectional analysis. Medicine, 95(20), e3572. https://doi.org/10.1097/MD.0000000000003572

Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., Azizi, M., Benetos, A., Borghi, C., Hitij, J. B., Cifkova, R., Coca, A., Cornelissen, V., Cruickshank, J. K., Cunha, P. G., ... Kjeldsen, S. E. (2023). 2023 ESH Guidelines for the management of arterial hypertension. Journal of Hypertension, 41(12), 1874–2071. https://doi.org/10.1097/HJH.0000000000003480

McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., Hanssen, H., Harris, J., Lauder, L., McManus, R. J., Molloy, G. J., Rahimi, K., Regitz-Zagrosek, V., Rossi, G. P., Sandset, E. C., ... ESC Scientific Document Group. (2024). 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal, 45(38), 3912–4018. https://doi.org/10.1093/eurheartj/ehae178

Muntner, P., Shimbo, D., Carey, R. M., Charleston, J. B., Gaillard, T., Misra, S., Myers, M. G., Ogedegbe, G., Schwartz, J. E., Townsend, R. R., Urbina, E. M., Viera, A. J., White, W. B., & Wright, J. T. (2019). Measurement of blood pressure in humans: A scientific statement from the American Heart Association. Hypertension, 73(5), e35–e66. https://doi.org/10.1161/HYP.0000000000000087

NCD Risk Factor Collaboration (NCD-RisC). (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398(10304), 957–980. https://doi.org/10.1016/S0140-6736(21)01330-1

Rashikh, M. A., Alruways, A. F., Alotaibi, H. B., Alotaibi, N. A., Almarshad, F., Alsaab, S. M., & Alotaibi, G. (2023). Blood pressure control and prescription pattern of antihypertensive drugs in adherence to the 2020 International Society of Hypertension global hypertension practice guidelines in Saudi Arabia: A retrospective study. Cureus, 15(2), e34965. https://doi.org/10.7759/cureus.34965

Rastogi, R., Sheehan, M. M., Hu, B., Shaker, V., Kojima, L., & Rothberg, M. B. (2021). Treatment and outcomes of inpatient hypertension among adults with noncardiac admissions. JAMA Internal Medicine, 181(3), 345–352. https://doi.org/10.1001/jamainternmed.2020.7501

Tucker, K. L., Sheppard, J. P., Stevens, R., Bosworth, H. B., Bove, A., Bray, E. P., Earle, K., George, J., Godwin, M., Green, B. B., Hebert, P., Hobbs, F. D. R., Kantola, I., Kerry, S. M., Leiva, A., Magid, D. J., Mant, J., Margolis, K. L., McKinstry, B., ... McManus, R. J. (2017). Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLOS Medicine, 14(9), e1002389. https://doi.org/10.1371/journal.pmed.1002389

Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., Wainford, R. D., Williams, B., & Schutte, A. E. (2020). 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 75(6), 1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026

Vrijens, B., Antoniou, S., Burnier, M., de la Sierra, A., & Volpe, M. (2017). Current situation of medication adherence in hypertension. Frontiers in Pharmacology, 8, 100. https://doi.org/10.3389/fphar.2017.00100

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Jr., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Sr., ... Wright, J. T., Jr. (2018). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13–e115. https://doi.org/10.1161/HYP.0000000000000065

World Health Organization. (2021). Guideline for the pharmacological treatment of hypertension in adults. https://www.who.int/publications/i/item/9789240033986

World Health Organization. (2023). Global report on hypertension: The race against a silent killer. https://www.who.int/publications/i/item/9789240081062

Downloads

Published

2026-10-02

How to Cite

Anggraini, T., Hartono, H., & Mursiany, A. (2026). Rationality of Antihypertensive Therapy and Blood Pressure Control in Comorbid Inpatients. Indonesian Journal of Global Health Research, 8(5), 1239–1246. https://doi.org/10.37287/ijghr.v8i5.2469

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.